FOR IMMEDIATE RELEASE -- PR Web Press Release

RxPrep iPhone Training for Pharmacists

Aliso Viejo, CA February 05, 2010 -- According to the Bureau of Labor Statistics, employment of pharmacists is expected to grow by 22 percent between 2006 and 2016.* To support this training effort, RxPrep has just released an iPhone/iPod Touch Application to assist students preparing for NAPLEX Board Review Exam. RxPrep is the industrys leading resource for Pharmacy Licensure training since 2001, having helped over 10,000 students successfully prepare for and pass the NAPLEX and CPJE exams. RxPreps NAPLEX Board Review courses have been delivered to pharmacy schools and leading chains throughout the United States. Priced at $39.99 and developed by iPhone training specialists, Netframes, the RxPrep application provides:

1. 300 real-world case-based multiple choice questions with scoring and explanations.
2. Subjects include: Cardiovascular Disease, Endocrine & Pulmonary, Infectious Disease, Neurology & Psychiatry, Mens & Womens Health, Geriatrics, and Gastrointestinal/Liver.
3. Online and phone customer support.
4. $100 off the purchase of any training intensive (live or online program) offered by RxPrep.

There are thousands of drugs. Where should study begin? This application gears the user towards the drugs that are top-sellers and the drugs that pharmacists manage in community and acute-care settings. As the licensing exam becomes more clinical, RxPrep will help the user focus on the key points of both common and critical medications.

Source: Pharmacy Profession Statistics: Bureau of Labor Statistics 2008 - 2009 Edition
Employment of pharmacists is expected to grow by 22 percent between 2006 and 2016, which is much faster than the average for all occupations. The increasing numbers of middle-aged and elderly peoplewho use more prescription drugs than younger peoplewill continue to spur demand for pharmacists throughout the projection period. Other factors likely to increase the demand for pharmacists include scientific advances that will make more drug products available and the coverage of prescription drugs by a greater number of health insurance plans and Medicare.